All Stories

  1. Beyond rurality: Regional and service-system variation in cancer patient experience in Scotland
  2. Personalised prediction of institutionalisation in Parkinson's: prognostic factor identification and model development and validation using IPD meta-analysis
  3. Prognosis in Parkinson's Disease: An Individual Patient Data Meta‐Analysis of Six European Incidence Cohorts
  4. Machine learning and statistical models for prediction of pregnancy outcomes in In vitro fertilization
  5. Beyond rurality: regional and service-system variation in cancer patient experience in Scotland
  6. Predicting natural conception leading to live birth for couples with infertility: a single-centre population-based cohort study of 7086 couples
  7. Evaluation of performance measures in predictive artificial intelligence models to support medical decisions: overview and guidance
  8. Geographic variation in experiences of cancer care in Scotland: insights and policy implications from the Scottish Cancer Patient Experience Survey
  9. Systematic review of prognostic models in Parkinson’s disease
  10. Patient-Centred Explainability in IVF Outcome Prediction
  11. Factors influencing time spent in hospital for unscheduled readmissions after stroke discharge
  12. Does Rose angina in midlife women matter? Further evidence from the Royal College of General Practitioners' Oral Contraception Study
  13. Predictors of success after in vitro fertilization
  14. Incidence and risk factors of institutionalisation in Parkinson's disease and atypical parkinsonism
  15. External validation of models for predicting cumulative live birth over multiple complete cycles of IVF treatment
  16. Early pregnancy outcomes of IVF cycles using donor versus partner sperm: analysis of 1 376 454 cycles recorded by the Human Fertilisation and Embryology Authority (1991–2016)
  17. Quality of clinical prediction models in in vitro fertilisation: Which covariates are really important to predict cumulative live birth and which models are best?
  18. ESHRE good practice recommendations on recurrent implantation failure
  19. A comparison of perinatal outcomes following fresh blastocyst or cleavage stage embryo transfer in singletons and twins and between singleton siblings
  20. Assessing Performance and Clinical Usefulness in Prediction Models With Survival Outcomes: Practical Guidance for Cox Proportional Hazards Models
  21. Myocardial infarction risk is increased by periodontal pathobionts: a cross-sectional study
  22. Perinatal outcomes of 221,709 singleton and twin pregnancies after the use of donor versus partner sperm
  23. Comparison of perinatal outcomes after frozen or fresh embryo transfer: separate analyses of singleton, twin, and sibling live births from a linked national in vitro fertilization registry
  24. Predicting cumulative live birth for couples beginning their second complete cycle of in vitro fertilization treatment
  25. Individual participant data meta-analysis of trials comparing frozen versus fresh embryo transfer strategy (INFORM): a protocol
  26. Assessing performance and clinical usefulness in prediction models with survival outcomes: practical guidance for Cox proportional hazards models
  27. Predicting personalized cumulative live birth following in vitro fertilization
  28. Should we adopt a prognosis-based approach to unexplained infertility?
  29. Prevalence of PErioperAtive CHildhood obesitY in children undergoing general anaesthesia in the UK: a prospective, multicentre, observational cohort study
  30. Is stroke incidence increased in survivors of adult cancers? A systematic review and meta-analysis
  31. Predicting 10-year stroke mortality: development and validation of a nomogram
  32. O-073 Perinatal outcomes of infants conceived using partner versus donor sperm - An analysis of singleton and twin pregnancies from the UK national dataset
  33. Predictive models of individual risk of elective caesarean section complications: a systematic review
  34. Validation of Risk Prediction Models to Inform Clinical Decisions After Acute Kidney Injury
  35. Women’s perspectives on smartphone apps for fertility tracking and predicting conception: a mixed methods study
  36. Erratum to: Development of a clinical risk score for pain and function following total knee arthroplasty: results from the TRIO study
  37. Outcomes following Notched Ruthenium-106 Plaque Brachytherapy for Juxtapapillary Choroidal Melanomas
  38. Prioritizing IVF treatment in the post-COVID 19 era: a predictive modelling study based on UK national data
  39. Outcomes of pregnancies using donor sperm compared with those using partner sperm: systematic review and meta-analysis
  40. Variations in Rates of Discharges to Nursing Homes after Acute Hospitalization for Stroke and the Influence of Service Heterogeneity: An Anglia Stroke Clinical Network Evaluation Study
  41. Cumulative live birth rates following blastocyst- versus cleavage-stage embryo transfer in the first complete cycle of IVF: a population-based retrospective cohort study
  42. Predicting risk of postpartum haemorrhage: a systematic review
  43. Age-related natural fertility outcomes in women over 35 years: a systematic review and individual participant data meta-analysis
  44. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
  45. Incidence of paediatric unplanned day-case admissions in the UK and Ireland: a prospective multicentre observational study
  46. Influences of rurality on action to diagnose cancer by primary care practitioners – Results from a Europe-wide survey in 20 countries
  47. A systematic review of the quality of clinical prediction models in in vitro fertilisation
  48. Making the Most of Your Data: Using an Alternative Statistical Methodology to Multilevel Modeling to Investigate Hospital Effects on Acute Hospital Length of Stay Following Stroke When Number of Hospitals Is Small
  49. UK Stroke forum 2019 Abstract Supplement
  50. Calibration: the Achilles heel of predictive analytics
  51. A comparison of the beta‐geometric model with landmarking for dynamic prediction of time to pregnancy
  52. Three myths about risk thresholds for prediction models
  53. Hospital-Level Variations in Rates of Inpatient Urinary Tract Infections in Stroke
  54. Treatment-independent live birth after in-vitro fertilisation: a retrospective cohort study of 2,133 women
  55. Individual and Combined Impact of Heart Failure and Atrial Fibrillation on Ischemic Stroke Outcomes
  56. Myocardial infarction after acute ischaemic stroke: Incidence, mortality and risk factors
  57. IVF for unexplained subfertility; whom should we treat?
  58. Predicting the chances of having a baby with or without treatment at different time points in couples with unexplained subfertility
  59. Does service heterogeneity have an impact on acute hospital length of stay in stroke? A UK-based multicentre prospective cohort study
  60. Is IUI with ovarian stimulation effective in couples with unexplained subfertility?
  61. External validation of a dynamic prediction model for repeated predictions of natural conception over time
  62. Predicting kidney failure risk after acute kidney injury among people receiving nephrology clinic care
  63. An improvement in the method used to assess discriminatory ability when predicting the chances of a live birth after one or more complete cycles of in vitro fertilisation
  64. Predicting the cumulative chance of live birth over multiple complete cycles of in vitro fertilization: an external validation study
  65. NDT Abstract Supplement 2018
  66. A mixed methods exploratory study of women’s relationships with and uses of fertility tracking apps
  67. Development of a clinical risk score for pain and function following total knee arthroplasty: results from the TRIO study
  68. Constructing the crystal ball: how to get reliable prognostic information for the management of subfertile couples
  69. Cumulative live birth rates following miscarriage in an initial complete cycle of IVF: a retrospective cohort study of 112 549 women
  70. Post-discharge kidney function is associated with subsequent ten-year renal progression risk among survivors of acute kidney injury
  71. Distinguishing variation in referral accuracy from referral threshold: analysis of a national dataset of referrals for suspected cancer
  72. A prognosis-based approach to infertility: understanding the role of time
  73. Socioeconomic Deprivation as Measured by the Index of Multiple Deprivation and Its Association with Low Sex Hormone Binding Globulin in Women
  74. Acute kidney injury as an independent risk factor for unplanned 90-day hospital readmissions
  75. Predicting the chances of a live birth after one or more complete cycles of in vitro fertilisation: population based study of linked cycle data from 113 873 women
  76. Clinical decision-making in azoospermic men: in search of the ideal prediction model
  77. Brief Report: Predicting Functional Disability: One-Year Results From the Scottish Early Rheumatoid Arthritis Inception Cohort
  78. Cumulative Live Birth Rates After 1 or More Complete Cycles of IVF
  79. Reply: Models for predicting live birth before a first IVF cycle
  80. Planned Repeat Cesarean Section at Term and Adverse Childhood Health Outcomes: A Record-Linkage Study
  81. Cumulative live birth rates after one or more complete cycles of IVF: a population-based study of linked cycle data from 178 898 women
  82. Planned Cesarean Delivery at Term and Adverse Outcomes in Childhood Health
  83. Blair Bell Research Society
  84. Predicting the chance of live birth for women undergoing IVF: a novel pretreatment counselling tool
  85. Cumulative live birth rate: time for a consensus?
  86. Abstract book of the 31stESHRE Annual Meeting, Lisbon, Portugal, 14–17 June 2015
  87. Internet information on birth options after caesarean compared to the RCOG patient information leaflet; a web survey
  88. Cardiovascular Magnetic Resonance Determinants of Left Ventricular Noncompaction
  89. Clinical prediction models to inform individualized decision-making in subfertile couples: a stratified medicine approach
  90. Cost of fertility treatment and live birth outcome in women of different ages and BMI
  91. Abstract book of the 30thESHRE Annual Meeting, Munich, Germany, 29 June – 2 July 2014
  92. Prediction of liver disease in patients whose liver function tests have been checked in primary care: model development and validation using population-based observational cohorts
  93. Validation of a short questionnaire for estimating dietary calcium intakes
  94. The epidemiology of infectious mononucleosis in Northern Scotland: a decreasing incidence and winter peak
  95. Impact of loop electrosurgical excision procedure for cervical intraepithelial neoplasia on HIV‐1 genital shedding: a prospective cohort study: population and statistical queries
  96. Does training in motivational interviewing for community pharmacists improve outcomes for methadone patients? A cluster randomised controlled trial
  97. The Utility of Liver Function Tests for Mortality Prediction within One Year in Primary Care Using the Algorithm for Liver Function Investigations (ALFI)
  98. Prevalence estimates of diagnosed viral hepatitis B, liver condition outcomes and hospitalization costs: a population record-linkage study in Tayside, Scotland
  99. Prevalence of common chronic respiratory diseases in drug misusers: a cohort study
  100. Reproductive Outcomes Following Ectopic Pregnancy: Register-Based Retrospective Cohort Study
  101. Do lifestyle choices explain the effect of alcohol on bone mineral density in women around menopause?
  102. PGI6 The Development and External Validation of a Model to Predict One Year All-Cause Mortality Following Liver Function Tests in Primary Care Patients
  103. Five-Year Prognosis in an Incident Cohort of People Presenting with Acute Myocardial Infarction
  104. O2-6.1 A second chance? Probability of a live birth following initial pregnancy loss: survival analysis of Scottish national data
  105. Fluvastatin does not prevent the acute-phase response to intravenous zoledronic acid in post-menopausal women
  106. Evaluation of patient reporting of adverse drug reactions to the UK ‘Yellow Card Scheme’: literature review, descriptive and qualitative analyses, and questionnaire surveys
  107. Minimising twins in in vitro fertilisation: a modelling study assessing the costs, consequences and cost-utility of elective single versus double embryo transfer over a 20-year time horizon
  108. Patient views and experiences of making adverse drug reaction reports to the Yellow Card Scheme in the UK
  109. Clinical effectiveness of elective single versus double embryo transfer: meta-analysis of individual patient data from randomised trials
  110. Considerable differences exist between prevalent and incident myocardial infarction cohorts derived from the same population
  111. 355 VALIDATION OF SELF-REPORTED OSTEOARTHRITIS IN A POSTMENOPAUSAL POPULATION AND ITS ASSOCIATIONWITH BODY WEIGHT
  112. Adverse Drug Reaction Reporting in the UK
  113. Session 20: Single Embryo Transfer & Art Pregnancy
  114. ABSTRACTS: 9th ISoP Annual Meeting ‘From Pharmacovigilance to Risk Management’, Reims, France, 6–9 October 2009
  115. Randomized controlled trial of intubation with the McGrath® Series 5 videolaryngoscope by inexperienced anaesthetists
  116. Patient Perspectives
  117. Five year prognosis in patients with angina identified in primary care: incident cohort study
  118. Fluvastatin does not prevent the acute-phase response to intravenous zoledronic acid in post-menopausal women
  119. Health outcomes following liver function testing in primary care: a retrospective cohort study
  120. Development of a decision support tool for primary care management of patients with abnormal liver function tests without clinically apparent liver disease: a record-linkage population cohort study and decision analysis (ALFIE)
  121. PG11 THE DEVELOPMENT AND PERFORMANCE OF MODELS TO PREDICT RISK OF LIVER DISEASE DIAGNOSIS FOLLOWING LIVER FUNCTION TESTING IN PRIMARY CARE
  122. PG119 THE COST-UTILITY OF LIVER DISEASE DIAGNOSIS: ASSESSING GP DECISIONS FOR PATIENTS WITH ABNORMAL LIVER FUNCTION TESTS AND NO OBVIOUS LIVER DISEASE
  123. PG121 REDUCTION OF WORK PRODUCTIVITY ASSOCIATED WITH GASTROESOPHAGEAL REFLUX DISEASE (GERD) AND RELATED COSTS
  124. Systematic Review: Health-State Utilities in Liver Disease: A Systematic Review
  125. A study of the safety of current gastrointestinal endoscopy (EGD)
  126. Development of a decision support tool to facilitate primary care management of patients with abnormal liver function tests without clinically apparent liver disease [HTA03/38/02]. Abnormal Liver Function Investigations Evaluation (ALFIE)
  127. Authors’ response
  128. PGI15 HEALTH-STATE UTILITIES IN LIVER DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
  129. Contributed Poster Presentations
  130. Receiver operating characteristics of the prostate specific antigen test in an unselected population
  131. Validating the Readiness for Interprofessional Learning Scale (RIPLS) in the postgraduate context: are health care professionals ready for IPL?
  132. Education
  133. How Safe Is Upper GI Endoscopy?
  134. Abstracts 1279 to 1393